This 6-session module focuses on using client-friendly explanations and shareable resources to help your pet owners understand the importance of early detection and treatment of skin tumors in dogs as well as available options for treatment of skin mast cell tumors (the most common skin cancer in dogs), including nonsurgical STELFONTA (tigilanol tiglate injection). You will receive a certificate once you completed all sessions. This course is RACE approved for 1 CE hour.

 

Access the Module

Session 1: Your Essential Role in Early Detection of Canine Skin Cancers (10 minutes)

Explore some simple ways you can help clients understand the importance of finding and fighting skin cancers.

 

Session 2: Understanding Mast Cell Tumors, the Most Common Skin Tumor (10 minutes)

Help motivate pet owners to be vigilant about regular at-home lumps-and-bumps checks with a working definition of mast cell tumors and an overview of diagnostic best practices.

 

Session 3: Treatment Options for Mast Cell Tumors (10 minutes)

Examine options for mast cell tumor treatment, some factors that influence treatment decisions, why some  pet owners may delay treatment and how STELFONTA can help eliminate multiple treatment bar riers.

 

Session 4: Introducing the Treatment Pet Owners Prefer: STELFONTA^® (tigilanol tiglate injection)(10 minutes)

Understand the specific indications for STELFONTA, and how it works to destroy mast cell tumors in dogs.

 

Session 5: Treatment Protocol for STELFONTA^® (tigilanol tiglate injection) (20 minutes)

Learn how to set client expectations for their dog's treatment, get information about mandatory pretreatment and posttreatment medications, and learn about aftercare and the posttreatment healing process.

 

Session 6: Tying It All Together: Case Studies and Pet Owner Experiences (20 minutes)

Walk through a case study that illustrates everything you've learned in sessions 1 -5, and gain insights into what pet owners say about their experiences with STELFONTA.

 

You will want to log into the Virbac eLearning system with the same login you use for this site (or the Virbac USA veterinary site).

 

Steps to get into the eLearning system:

1. Click the button above or go to us.learning.virbac.com.

2. Log into the eLearning system with Virbac Connect. 

3. Then click on Google Connect.

4. Once you are logged in, pick which course you want to take.

5. Take the course and complete it.

6. Once finished, your certificate will be emailed to the email address associated with your account.

7. If you have any issues, please reach out to email@virbacus.com.

 

Critical Note When Taking the Sessions:

• eLearning works best on desktop and in the Chrome browser

---

IMPORTANT SAFETY INFORMATION

FOR VETERINARIANS
Accidental self-injection of STELFONTA^® may cause severe wound formation. To decrease the risk of accidental self-injection, sedation of the dog may be necessary. In dogs, do not inject STELFONTA into subcutaneous mast cell tumors located above the elbow or hock. Formation of wounds, possibly extensive, is an intended and likely response to treatment with STELFONTA along with associated swelling, bruising and pain; these wounds are expected to heal. Appropriate pre- and post-treatment medications must be given, including a corticosteroid plus blocking agents for both H1 and H2 receptors, in order to decrease the potential for severe systemic adverse reactions, including death, from mast cell degranulation. For full prescribing information, contact VIRBAC at 1-800-338-3659 or view the Product Insert.